Collegium Pharmaceutical, Inc. COLL Debt Issuance Cost Amortization
Debt Issuance Cost Amortization at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCostsAndDiscounts.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s debt issuance cost amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s debt issuance cost amortization?
- Collegium Pharmaceutical, Inc. (COLL) reported debt issuance cost amortization of $819K in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s debt issuance cost amortization changed year-over-year?
- Collegium Pharmaceutical, Inc.'s debt issuance cost amortization decreased by 40.1% year-over-year, from $1.37M to $819K.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s debt issuance cost amortization?
- Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s debt issuance cost amortization has grown at a 11.9% compound annual growth rate (CAGR), from $3.41M to $5.34M.
- What does debt issuance cost amortization mean?
- Non-cash amortization of capitalized costs incurred to issue debt (underwriting fees, legal costs, SEC filing fees).